TITLE

An Update of Immunotherapy for Specific Allergies

AUTHOR(S)
Prescott, Susan L.; Jones, Catherine A.
PUB. DATE
March 2002
SOURCE
Current Drug Targets - Inflammation & Allergy;Mar2002, Vol. 1 Issue 1, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Allergic diseases are common, disabling and potentially life threatening. The processes that lead to production of excessive allergen-specific IgE production are highly complex and heterogeneous. While current treatment strategies are limited, recent technological advances have provided a better understanding of underlying disease processes and offered new potential therapeutic targets. Optimal treatment strategies permanently modify underlying inflammatory allergic immune responses (immunotherapy) with long term alleviation of symptoms and minimal side -effects. Although these processes are still not completely understood, methods of modifying allergen recognition by the immune system have already been successful. Here, we review recent developments and future directions in allergen immunotherapy and adjunctive therapies. Specifically, we address the molecular mechanisms of allergen immunotherapy and new techniques including allergen modification, allergen gene vaccination, CpG immunostimulation, and peptide immunotherapy. Other non-allergen specific molecular targets (including receptor, cytokine and IgE targets) which may complement specific immunotherapy are also discussed. Ideally these methods will eventually be replaced by strategies targeting the prevention of allergic responses (immunoprophylaxis).
ACCESSION #
11136335

 

Related Articles

  • Peptide-based Vaccines in the Treatment of Specific Allergy. C. Alexander; A. B. Kay; M. Larche // Current Drug Targets - Inflammation & Allergy;Dec2002, Vol. 1 Issue 4, p353 

    The efficacy of conventional allergen-specific immunotherapy (SIT) for allergic conditions and venom hypersensitivity is well documented. However it''s use is limited due allergic side effects including anaphylaxis and the difficulty of standardising proteins in complex allergenic mixtures. The...

  • Foreword. Durham, Strephen R. // Current Medical Literature: Allergy;2003, Vol. 11 Issue 3, pIV 

    Focuses on the increase prevalence of allergic disorder in Great Britain. Importance of an allergen-specific diagnosis; Availability of purified and recombinant allergens; Efficacy of allergen-specific immunotherapy.

  • The safety of allergen immunotherapy: A literature review. Cook, Paul R.; Fanas, Carlos // ENT: Ear, Nose & Throat Journal;May1998, Vol. 77 Issue 5, p378 

    Provides a literature review on the history of allergen immunotherapy. Safety of immunotherapy; Types of allergenic reactions to subcutaneous injections of allergenic extracts; Contraindication of immunotherapy.

  • Variability in practice patterns of shared-specific versus patient-specific immunotherapy by practicing allergists and allergy program directors and implications for practice parameters. Melamed, Julian; Sheikh, Javed; Maclean, James; Scott, Jordan; Seltzer, James; Bayuk, Jon // Allergy & Asthma Proceedings;Jul/Aug2010, Vol. 31 Issue 4, p363 

    The article discusses a survey of members of the Massachusetts Allergy and Asthma Society (MAAS) and allergy training program directors concerning their method of immunotherapy. It notes that there were significant differences between training directors and practicing allergists in their use of...

  • allergoid.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p80 

    An encyclopedia entry for "allergoid," a chemically altered allergen used in immunotherapy to induce antigen tolerance is presented.

  • Pet dander and perennial allergic rhinitis: Therapeutic options. Wallace, Dana V. // Allergy & Asthma Proceedings;Nov/Dec2009, Vol. 30 Issue 6, p573 

    Pet allergy may now be the most common perennial allergen in the United States based on recent skin-prick testing data. This trend corresponds with the rise (from 56 to 63%) in U.S. households having indoor pets over the past 10 years. Furthermore small, suspended, particulate animal allergens...

  • Injection immunotherapy. Frew, A.J. // BMJ: British Medical Journal (International Edition);10/9/93, Vol. 307 Issue 6909, p919 

    Investigates the role of allergen injection immunotherapy in treatment of allergic disease in Great Britain. Effectiveness and safety of injection immunotherapy; Use of injection for treatment of allergic rhinitis and asthma Availability of alternative treatment for allergic diseases.

  • Allergen Immunotherapy (Book). Carter, Phillip // American Scientist;Jul/Aug93, Vol. 81 Issue 4, p393 

    Reviews the non-fiction book 'Allergen Immunotherapy,' edited by Richard F. Lockey and Samuel C. Bukantz.

  • Patients' compliance with different administration routes for allergen immunotherapy in Germany. Egert-Schmidt, Anne-Marie; Kolbe, Jan-Marcel; Mussler, Sabine; Thum-Oltmer, Susanne // Patient Preference & Adherence;2014, Vol. 8, p1475 

    Background: Allergen immunotherapy (AIT) is the practice of administering gradually increasing quantities of an allergen extract to an allergic subject to ameliorate the symptoms associated with the subsequent exposure to the causative allergen. It is the only treatment that may alter the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics